
Available online at www.sciencedirect.com

Progress in Neuro-Psychopharmacology & Biological Psychiatry 28 (2004) 813–818

Review article

Ephrin signaling in axon guidance

Jacques Huot*

Le Centre de recherche en cancérologie de l’Université Laval, L’Hôtel-Dieu de Québec, 9, rue McMahon, Québec, Canada G1R 2J6

Accepted 10 May 2004

---

### Abstract

The multiple functions of a neuron depend on the proper assembly of axonal connections during the development of the nervous systems. This assembly involves the motile behavior of growth cones at the ends of elongating axons. The growth cones express receptors that bind to specific guidance molecules in the local environment. In turn, this initiates the attractive and repulsive forces required to give the appropriate direction to the elongating axon. The process implicates a tightly regulated remodeling of the actin cytoskeleton in response to the activation of the Rho GTPases, Cdc42, Rac and RhoA. In this article, we will review how the ephrin–Eph receptor system regulates the activity of the Rho GTPases, to modulate the mechanics of growth cone activity and then axon guidance.

© 2004 Published by Elsevier Inc.

Keywords: Axon guidance; Ephrins; Growth cone; Signaling

---

### Contents

1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2. Ephrins and Eph receptors

Eph receptors are members of the tyrosine kinase receptors. They are involved in outside-in signaling that originates from themselves (forward signaling) or from their plasma-membrane-bound ephrin ligands (reverse signaling). During cell–cell communication, Ephs and ephrins also control the output signal that emanates from inside the cells (inside-out signaling). Ephrins are grouped in two classes: ephrin-As, which are anchored to the membrane by a glycosylphosphatidylinositol (GPI) and ephrin-Bs, which have a transmembrane domain followed by a short cytoplasmic domain (Fig. 1). The ephrin A subclass contains ephrin A1 to A5 and the ephrin B subclass has three members ephrin B1 to B3 (Kullander and Klein, 2002). Eph receptors are divided into an A-subclass that contains eight members (EphA1–EphA8), and a B-subclass that contains five members (EphB1–EphB4, EphB6). A-type receptors bind to most or all A-type ligands, and B-type receptors bind to most or all B-type ligands. Exceptionally, EphA4 can bind both A-type and most B-type ligands.

![Diagram](attachment:diagram.png)

Fig. 1. Forward and reverse signaling by the ephrin–Eph complex. Glycosylphosphatidylinositol (GPI)-anchored ephrin-As bind to EphA receptors whereas the transmembrane ephrin-Bs bind to EphB receptors. The ephrin–Eph receptor binding initiate forward signaling in the Eph receptor bearing cells and reverse signaling in the cells that express ephrins. Major events associated with forward signaling involve the exchange factor ephexin, which links the Eph receptor with the Rho GTPases and then to regulation of actin remodeling. Other important events implicate the inactivation of focal adhesion kinase (FAK) and decreased integrin-mediated adhesion through activation of the phosphatases Shp2 by EphA. In contrast, the recruitment of the adaptor protein Nck to EphB and the activation of Src are associated with increased integrin-mediated adhesion. Reverse signaling by ephrin-Bs is characterized by the recruitment of SH2 domain containing protein such as Grb4 to phosphoryrosine residues on ephrin-Bs. PDZ-RGS3 are PDZ-binding proteins that bind to ephrin-Bs to modulate signaling through G-protein-coupled receptors. In the case of ephrin-As, the reverse signaling implies their aggregation with signaling molecules in membrane raft microdomains. Interestingly, their activity can be modulated by enzymatic cleavage by metalloproteases. SAM, sterile α motif; PDZ, PSD-95 disc large zonula occludens-1. Reproduced with permission from Nature Reviews Molecular Cell Biology, Kullander and Klein. Copyright 2002 Macmillan Magazines Ltd. (Kullander and Klein (2002)).
The extracellular domain of Eph receptors contains the ligand-binding domain, a cysteine-rich region and two fibronectin type III repeats (Fig. 1). Then follows a short transmembrane region that precedes the cytoplasmic domain. This latter comprises four functional units; the juxtamembrane domain with two conserved tyrosine residues, a tyrosine kinase domain, a sterile α motif (SAM) with its structure that could form dimers and oligomers and a PSD-95 disc large zonula occludens-1 (PDZ)-binding motif that contains a consensus binding sequence that includes a hydrophobic residue at the C-terminus. The ephrin–Eph receptors system regulates many cellular functions that depend upon cytoskeleton remodeling, such as axon guidance and synaptic plasticity. The influence of Eph–ephrin activation on cell behavior differs depending on cell type. They are generally associated with repulsion of neighboring cells or of cellular processes, such as the neuronal growth cone. However, in some cases, Eph–ephrin activation leads to increased adhesion or attraction.

### 3. Signaling through Ephrin and Eph receptors

The binding of ephrins to their Eph receptors induces “forward signaling”, in the Eph expressing cells and reverse signaling in the Ephrin expressing cells especially those that express the ephrins of the B family. This implicates that both the ligand and the receptor rearrange upon binding and adopt the active conformation that initiates signals into both interacting cells. The Eph receptors are activated following their binding to pre-clustered membrane attached ephrin ligands. Eph receptors bind ephrins with a nanomolar affinity and with a 1:1 stoichiometry. The newly formed Eph–ephrin heterodimers lead to complementary interactions that result in formation of tetrameric complexes. This shapes the orientation of the participating ligands and receptors. The intrinsic kinase activity of the Eph receptors becomes activated leading to auto- and transphosphorylation of the Eph on tyrosine residues initiating forward signaling through recruitment and interactions with the Src homology domain-2 (SH2) domains of target scaffold or adaptor proteins. The C-terminal PDZ-binding motif of some Ephs is also involved in interactions with adaptor proteins, including AF6. In turn, this latter binds other signaling molecules including the Ryk receptor (Kullander and Klein, 2002). The formation of the Eph–ephrin heterotetramers repositions the ephrin transmembrane and cytoplasmic domains, converting them into a signaling configuration. This is followed by phosphorylation of the ephrin cytoplasmic tail on tyrosine residues initiating reverse signaling through the SH2 domain-containing growth factor receptor-bound protein (Grb) 4 and/or through regulation of G-protein signaling. Ephrin-A proteins can also deliver reverse signals, activating for example the intracellular tyrosine kinase Fyn. Most often, Eph signaling results in collapse of cell processes, down-regulation of adhesion molecules and cell detachment. However, depending on receptor density, the same EphA8/ephrin complex can induce dramatically opposing cellular responses namely integrin-dependent adhesion versus repulsion (Boyd and Lackmann, 2001).

### 4. Ephrin and Eph receptors as regulators of growth cone activity and axon guidance

#### 4.1. Structural composition of the growth cone

As mentioned above, growth cones are specialized and sensitive cytoskeletal motile structures located at the tips of developing axons (Gallo and Letourneau, 2004; Zhou and Cohan, 2004). Their activity, in response to guidance cues, is the major determinant of axon guidance and elongation during development and it also contributes to axon regeneration after nerve injury. Growth cones are the most plastic area of the developing axon (Chan et al., 2003). Accordingly, their cytoskeleton differs from that of the axon being characterized by constant and rapid remodeling. Structurally, the growth cone contains a peripheral and a central domain (P- and C domains; Fig. 2). At the peripheral domain (P domain), actin meshwork is concentrated at the leading edge and it undergoes actin polymerization-mediated extrusion of filopodia and lamellipodia. These projections are usually followed by retraction that depends upon myosin-mediated retrograde flow of actin filaments. The extrusion/retraction cycle constitutes the basis that underlies actin-based motility of the growth cone. Interestingly, the turning of the growth cones is tightly dependent upon the movement of the filopodia. In fact, without filopodia, the growth cones become disoriented. It is believed that filopodia steer the growth cones by differential adhesion, generating mechanical forces or transducing distal signals (Dickson, 2002).

Microtubules are the other major structural element of the growth cone that is involved in axon extension. They project from the axon shaft of the C-domain of the growth cone. At the end of the microtubule bundles, individual microtubules spread apart and some of them invade the actin rich P-domain. These microtubules are characterized by dynamic instability associated with tubulin polymerization (Fig. 2). The microtubule cytoskeleton also plays a role in growth cone motility and its dynamics is also regulated by guidance cues following engagement with membrane receptors. Recent work has revealed an interaction between actin structures and microtubules of the growth cone cytoskeleton that is probably essential for growth cone turning (Gordon-Weeks, 2004). Interestingly, growth cones contain highly dynamic neurofilament subunits that may also contribute to axonal elongation (Chan et al., 2003). A prominent question to understand how the remodeling of growth cone steers axon guidance is to know how they sense and respond to guidance molecules such as ephrins.
J. Huot / Progress in Neuro-Psychopharmacology & Biological Psychiatry 28 (2004) 813–818

Filipodium

F-actin bundles

Dynamic microtubule filaments

F-actin network

Stable microtubule bundles

Filipodial initiation

Barbed-end actin assembly

Retrograde F-actin flow

Microtubule capture and stabilization

Fig. 2. Schematic representation of a growth cone. The dynamic interplay between actin and microtubule cytoskeleton structures are shown. Adapted from Dickson (2002). Reprinted with permission from Fig2A from Dickson, Science 298: 1959–64 (2002). Copyright 2002 AAAS.

### 4.2. Regulation of growth cone dynamics by ephrin and Eph receptors

The small GTPases of the Rho family are centrally involved in regulating actin dynamics. Typically, Cdc42, Rac and RhoA are responsible for the formation of filopodia, lamellipodia and stress fibers, respectively. Moreover, microinjection experiments in fibroblasts have revealed a cascade of activation in which Cdc42 is upstream of Rac, and Rac upstream of RhoA (Lamarche et al., 1996; Nobes and Hall, 1995). Several studies have confirmed the central role of the Rho GTPases in regulating actin cytoskeleton and have extended the classical notions of the group of Alan Hall. For example, we have shown in endothelial cells that activation of Cdc42 downstream from phosphorylation of Y1214 on vascular endothelial growth factor receptor (VEGFR) 2 activates the mitogen-activated protein (MAP) kinase stress-activated protein kinase (SAPK)2/p38, independently of RhoA, which triggers actin polymerization and formation of stress fibers (Lamalice et al., 2004). The small Rho GTPases are also major player of growth cone remodeling and axon guidance.

Consistent with its role in axon guidance and cell migration, Eph-mediated forward signaling regulates actin dynamics via activation of the small GTPases of the Rho family. The first evidence linking Ephs and the Rho GTPases were obtained in the axons of the retinal ganglion where ephrin-A5 signaling leads to activation of RhoA and ROCK and to inactivation of Rac (Wahl et al., 2000). Thereafter, major breakthroughs have been obtained following the identification of the exchange factor ephexin (Eph-interacting exchange factor), since its discovery allowed to establish a direct functional link between EphA receptors, Rho GTPases, and the cytoskeleton (Shamah et al., 2001). Ephexin is constitutively bound to EphA4. Upon activation of EphA4, ephexin activates RhoA and simultaneously inhibits Cdc42 and Rac1, which inhibits p21-activated protein kinase (PAK) and PAK-mediated events. Ultimately, this promotes collapse and retraction of the growth cone. Intriguingly, activation of Eph receptors also inhibits Ras. In the case of EphB2, the inhibition of Ras leads to inactivation of extracellular signal-regulated kinase, and retraction of neurites (Miao et al., 2001). The mechanism by which Ephs control Ras activity remains to be determined. It may involve the SH2 domain-mediated recruitment and activation of RasGAP leading to the hydrolysis and inhibition of activated Ras-GTP (Holland et al., 1997). More distally, activation of RhoA conveys

messages that converge on actin remodeling/motility of the growth cones including, Arp2/3 (nucleation of new actin filament), ena/VASP proteins, tropomyosin (actin elongation), integrins (coupling of actin filaments to the substrate) and myosin (regulation retrograde flow of actin filaments) (Dickson, 2002; Gallo et al., 2002; Houle et al., 2003). Another direct link between Eph and actin cytoskeleton is via the modulation of Abl phosphorylation, a non-receptor tyrosine kinase that contains an actin binding motif and that associates with Eph receptors (Yu et al., 2001). However, the role of Eph–Abl connection in regulating growth cones activity is unknown.

The literature concerning the reverse signaling by Ephrins B is growing fast and its role in axon guidance is emerging. Notably, tyrosine phosphorylation of the Ephrin-B cytoplasmic domains mediates Ephrin-B reverse signaling through the recruitment of Grb4 (Fig. 1). Grb4 binds, via its SH2 domain, to the phosphotyrosine residues on ephrin-B, which regulates the activity of focal adhesion kinase and the turnover of focal adhesions and stress fibers. However, it is unknown whether this actin remodeling is involved in regulating growth cone activity and axon guidance. Interestingly, ephrins B also contain C-terminal PDZ ligand motif that is critical for reverse signaling and that can be involved in axon guidance. In particular, some PDZ-domain proteins bind to ephrin-Bs, including PDZ-RGS3 a regulator-of-heterotrimeric G protein-signaling domain, which inhibits signaling downstream from seven-transmembrane G proteins coupled receptors. Interestingly, stromal-cell-derived factor-1 (SDF-1)-induced cerebellar granule cell migration is inhibited by the stimulation of ephrin-B with EphB2 receptor bodies, and this effect is mediated by PDZ-RGS3 (Lu et al., 2001). These findings support the idea that neuronal guidance cues may regulate motility and chemotaxis through control of G protein-coupled activities.

Of note, several mechanisms may be involved in regulating the ephrins–Eph system signaling to modulate axonal actin responsiveness to guidance cues. Notably, contact-mediated repulsion can be regulated by cleavage of ephrin-A2 by a metalloprotease activated in response to binding to EphA3 receptor (Huber et al., 2003). Moreover, EphA2 mRNA is translated locally within distal axons after their projection beyond target regions (Brittis et al., 2002). All these findings indicate that growing axons contain the machinery necessary for local translation and membrane insertion of guidance receptors adjusting receptor profiles on growth cones and responsiveness to the local external environment.

### 5. Efrins and Eph receptors in axon guidance in the visual system

Ephrins control axon guidance in several locations. For example, the ephrin–Eph system is critically involved in axon guidance at the midline where commissural axons cross to the contralateral side. At least three mechanisms of Eph–Ephrin action are involved, and they implicate both forward and reverse signaling. First, ephrin-B ligands expressed by midline cells are selective repellents for subsets of axons and prevent them from crossing the midline. Second, ephrin-B defines the position of longitudinally projecting commissural axons after they have crossed the midline. Third, ephrin-B expressed by commissural axons act as signaling-competent guidance receptors (Palmer and Klein, 2003).

The ephrins–Eph complexes also regulate axon guidance in the visual system. In particular, ephrin-A ligands and Eph A receptors-mediated repulsion is typically involved in regulating the mapping of retinal axons along the anterior-posterior axis. Ephrin-A ligands are expressed in a gradient in the superior colliculus, and EphA receptors are expressed in a complementary gradient in the retinal axons. The retinal axons with the higher EphA levels map to lower points along the ephrin-A gradient. If this latter is lost, then, retinal axons still fill the entire superior colliculus but the topographic order is disrupted and some axons shift posteriorly and others anteriorly (Feldheim et al., 2000). Hence, the ephrin-A gradient establishes the topographic order of retinal axons, but not their termination sites. Along these lines, gene targeting elevation of EphA receptor expression in a subset of mouse ganglion cells is associated with the production of two intermixed ganglion cell populations that express distinct EphA receptor gradients. As expected, these two populations form separate maps in the colliculus (Brown et al., 2000). Intriguingly, mapping along the dorsal-ventral axis involves attractive instead of repulsive signaling. This attractive signaling is mediated by ephrin-B ligands and EphB receptors (Hindges et al., 2002). Correct mapping of retinal axons along this axis requires both “forward” signaling, in which ephrin-B ligands activate EphB receptors, and “reverse” signaling, in which EphBs serve as ligands to signal back through the transmembrane Ephrin-Bs (Dickson, 2002).

Overall, these studies indicate that ephrin ligands and their Eph receptors are involved in both forward and reverse signaling, and that these signaling are both implicated in regulating axon guidance.

### 6. Future directions

Several questions remain open. In particular, a major challenge is to understand further the mechanisms by which the ephrin–Eph receptor systems regulate the functions of the nervous system in the adult. For example, the understanding of their role in axon regeneration might be crucial for treating patients suffering from nerve injuries and sectioning. In another context, the ephrin ligands–Eph receptors are critically involved in modulating angiogenesis. Here again, the understanding of the mechanism involved might reveal important clues to treat diseases such as cancer that required neovascularization.

Acknowledgements

The author would like to thank François Houle for drawing the figures.

This manuscript is dedicated to Corneille Radouco-Thomas who was my mentor and became my friend. With him, I wrote my first article that was published in *Int. Z. Klin. Pharmakol. Ther. Toxikol.* 3 (1971) 231–248. The title was “Pharmacomolecules–protein bioreceptor interactions”. This title was a little ahead of its time and it well characterized Dr. Radouco-Thomas, a creative man with a far vision on the future. Some 25 years ago, we both attended a Summer School in Lake Placid, NY that bears on “Axon Guidance”. In my manuscript, I chose this topics hoping that it will bring responses to some of the many questions that were raised by Dr. Radouco-Thomas, but for which nobody has answers at that time.

References

Boyd, A.W., Lackmann, M., 2001. Signals from Eph and ephrin proteins: a developmental tool kit. Sci. STKE 2001, RE20.

Brittis, P.A., Lu, Q., Flanagan, J.G., 2002. Axonal protein synthesis provides a mechanism for localized regulation at an intermediate target. Cell 110, 223–235.

Brown, A., Yates, P.A., Burrola, D., Ortuno, D., Vaidya, A., Jessell, T.M., Pfaff, S.L., O’Leary, D.D., Lemke, G., 2000. Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling. Cell 102, 77–88.

Chan, W.K., Yabe, J.T., Pimenta, A.F., Ortiz, D., Shea, T.B., 2003. Growth cones contain a dynamic population of neurofilament subunits. Cell Motil. Cytoskelet. 54, 195–207.

Dickson, B.J., 2002. Molecular mechanisms of axon guidance. Science 298, 1959–1964.

Feldheim, D.A., Kim, Y.I., Bergemann, A.D., Frisen, J., Barbacid, M., Flanagan, J.G., 2000. Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping. Neuron 25, 563–574.

Gallo, G., Letourneau, P.C., 2004. Regulation of growth cone actin filaments by guidance cues. J. Neurobiol. 58, 92–102.

Gallo, G., Yee Jr., H.F., Letourneau, P.C., 2002. Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility. J. Cell Biol. 158, 1219–1228.

Gordon-Weeks, P.R., 2004. Microtubules and growth cone function. J. Neurobiol. 58, 70–83.

Hindges, R., McLaughlin, T., Genoud, N., Henkemeyer, M., O’Leary, D.D.,

2002. EphB forward signaling controls directional branch extension and arborization required for dorsal-ventral retinotopic mapping. Neuron 35, 475–487.

Holland, S.J., Gale, N.W., Gish, G.D., Roth, R.A., Songyang, Z., Cantley, L.C., Henkemeyer, M., Yancopoulos, G.D., Pawson, T., 1997. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J. 16, 3877–3888.

Houle, F., Rousseau, S., Morrice, N., Luc, M., Mongrain, S., Turner, C.E., Tanaka, S., Moreau, P., Huot, J., 2003. Extracellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeleton remodeling in response to oxidative stress: impact on membrane blebbing. Mol. Biol. Cell 14, 1418–1432.

Huber, A.B., Kolodkin, A.L., Ginty, D.D., Cloutier, J.F., 2003. Signaling at the growth cone: ligand–receptor complexes and the control of axon growth and guidance. Annu. Rev. Neurosci. 26, 509–563.

Kullander, K., Klein, R., 2002. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev., Mol. Cell Biol. 3, 475–486. www.nature.com/reviews<http://www.nature.com/reviews>.

Lamalice, L., Houle, F., Jourdan, G., Huot, J., 2004. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 23, 434–445.

Lamarche, N., Tapon, N., Stowers, L., Burbelo, P.D., Aspenstrom, P., Bridges, T., Chant, J., Hall, A., 1996. Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 87, 519–529.

Lu, Q., Sun, E.E., Klein, R.S., Flanagan, J.G., 2001. Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemotraction. Cell 105, 69–79.

Miao, H., Wei, B.R., Peehl, D.M., Li, Q., Alexandrou, T., Schelling, J.R., Rhim, J.S., Sedor, J.R., Burnett, E., Wang, B., 2001. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat. Cell Biol. 3, 527–530.

Nobes, C.D., Hall, A., 1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53–62.

Palmer, A., Klein, R., 2003. Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. Genes Dev. 17, 1429–1450.

Shamah, S.M., Lin, M.Z., Goldberg, J.L., Estrach, S., Sahin, M., Hu, L., Bazalakova, M., Neve, R.L., Corfas, G., Debant, A., Greenberg, M.E., 2001. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 105, 233–244.

Wahl, S., Barth, H., Ciossek, T., Aktories, K., Mueller, B.K., 2000. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J. Cell Biol. 149, 263–270.

Yu, H.H., Zisch, A.H., Dodelet, V.C., Pasquale, E.B., 2001. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor. Oncogene 20, 3995–4006.

Zhou, F.Q., Cohan, C.S., 2004. How actin filaments and microtubules steer growth cones to their targets. J. Neurobiol. 58, 84–91.
